Forging a path for MedTech Innovation.


A Weight Lifted – Paths Forward for MedTech in the GLP-1 Era
How are GLP-1s impacting the MedTech industry? IQVIA MedTech cut through noise and speculation to uncover not only the challenges but the opportunities.
00:00:00 – Webinar Introduction
Matt Stewart opens the webinar by introducing our speakers and the context for the webinar.
00:01:44 – The origins of the GLP-1 explosion
Joanna Wills introduces the topic with a brief background in GLP-1s, the hidden positive GLP-1 physiological effects, the second generation of GLP-1s, the recent impact of GLP-1s, and what is coming down in the pipeline that could impact MedTech.
00:16:30 – Assessing the real impact of GLP-1s on MedTech
Michelle Edwards gives examples of where RWE can help assess GLP-1 impact in Orthopaedics and Diabetes, the complexity of it’s potential impact in the cv-met space, and covers important considerations for MedTech.
00:32:09 – Taking the right step forward
Chris Ludwig outlines the key building blocks to mastering the GLP-1 future, combining data assets, analysis/consulting, and real-world evidence. Chris also takes a look at social media intelligence, revealing interesting insights into patient motivations and outcomes.
00:42:18 – How IQVIA MedTech is supporting the industry
Chris Ludwig briefly explains how IQVIA MedTech is supporting the industry in this area.
00:43:10 – Q&A
Our panel of speakers tackle some audience questions, and the webinar concludes.
You can download the presentation here.
IQVIA MedTech has the expertise and connected intelligence to support you on your GLP-1 journey. If you have a request for a proposal in any area discussed during this webinar, please click the “CONTACT US” button floating on this page to make an enquiry.
Forging a path for MedTech Innovation.